TY  - CONF

T1  - Tolerability of gemcitabine in paclitaxel-containing, epirubicin/cyclophosphamide-based, adjuvant chemotherapy in the randomized phase III tAnGo trial for invasive higher risk early stage breast cancer.

JO  - BREAST CANCER RESEARCH AND TREATMENT

PY  - 2006/01/01

AU  - Poole CJ

AU  - Hiller L

AU  - Howard HC

AU  - Loi S

AU  - Dunn JA

AU  - Canney P

AU  - Wardley AM

AU  - Crown JP

AU  - Coleman RE

AU  - Verrill MW

AU  - Ellis PA et al

ED  - 

VL  - 100

SP  - S114

EP  - S114

Y2  - 2025/10/10

ER  -